Latest Investment Funds biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Orikine Bio closes €5.5m Series Seed Financing with Sabadell Asabys and AdBio

by Asabys Partners

9 months ago
Foldikines©, Cytokines, Asabys Partners, Orikine Bio

Orikine Bio, a biotech company developing a novel proprietary platform for cytokine-based therapies for autoimmune and inflammatory diseases, announces today the successful closing of a €5.5m seed f...

AbilityPharma will secure 7 million euros with a collective investment campaign in Capital Cell of up to 2 million to finance itself until the results of its international phase 2b study in pancreatic cancer

by Ability Pharma

8 months ago
Capital Cell, AbilityPharma

The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes a collective investment campaign of up to 2 million on the Capital C...

Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys

by Asabys Partners

8 months ago
Gradient Denervation Technologies, pulmonary hypertension, heart failure, Sabadell Asabys, Sabadell Asabys II

Gradient Denervation Technologies (“Gradient”), a medical device company developing an innovative catheter-based solution for the treatment of pulmonary hypertension, announces today the successfu...

ICF invests €10M in Asabys fund II, which has already 3 companies in its portfolio

by Asabys Partners

8 months ago
ICF, Asabys

Asabys has announced that the Institut Català de Finances (ICF) has joined its new venture capital fund, Sabadell Asabys Health Innovation Investments II (Sabadell Asabys II), with 10 million euros. ...

Am-Pharma announces updated clinical development strategy

by Ysios Capital

7 months ago
ilofotase alfa, AM-Pharma, hypophosphatasia

Advancing ilofotase alfa into a Phase 2 study for lead indication cardiac surgery-associated renal damage

ADmit therapeutics closes a €5.4 million funding round led by Clave Capital, through its Clave Innohealth f.c.r. fund.

by ADmit Therapeutics

7 months ago
MAP-AD, Mild Cognitive Impairment (MCI), Alzheimer's disease (AD), Clave Capital, ADmit Therapeutics

ADmit Therapeutics is a biotechnology company founded at the end of 2017 as a spin-off from the Bellvitge Biomedical Research Institute (IDIBELL). The company is focused on the development and commerc...

OneChain Immunotherapeutics achieves FDA Orphan Drug designation for OC-1

by Parc Científic de Barcelona

7 months ago
OneChain Immunotherapeutics, acute lymphoblastic leukemia (ALL), OC-1

Spanish biotech OneChain Immunotherapeutics (OCI), has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA)to OC-1, a CAR T therapy against for the treatment of acute lymp...

Renalyse has successfully closed an investment round of 1 M€ led by Mind the Gap and with participation from GENESIS Ventures and the Eurostars program

by GENESIS Biomed

7 months ago
Renalyse, Botín Foundation, Genesis Ventures

Renalyse, also known as CreatSens Health, has concluded an investment round led by the Mind the Gap program of the Botín Foundation, with participation from GENESIS Ventures and the Eurostars program...

Asabys’ portfolio company Agomab Raises $100 Million Series C from Fidelity, EQT Life Sciences, Canaan and KKR

by Asabys Partners

7 months ago
AGMB-129, Fibrostenosing Crohn’s Disease (FSCD), Agomab, Idiopathic Pulmonary Fibrosis, Asabys

Agomab Therapeutics NV ('Agomab') today announced the closing of a $100 million Series C round of financing to support the Phase 2a clinical trial evaluating Agomab's lead drug candidate, AGMB-129, a ...

CPC mouthwashes reduce herpes simplex type 1 infectivity herpes simplex type 1 infectivity

by IrsiCaixa

7 months ago
cetylpyridinium chloride (CPC), Herpes simplex virus type 1

CPC-containing mouthwashes could be a safe, easy and cost-effective measure to limit infectivity and the ability to transmit viruses

La Fundación 'la Caixa' impulsa dos proyectos biomédicos de CIC bioGUNE para trasladar sus investigaciones punteras del laboratorio a los pacientes

by CIC bioGUNE

6 months ago
proteína WNT11, ARN, CaixaImpulse Innovación, Fundación “la Caixa”, CIC bioGUNE

Entre los seleccionados de este año se encuentran dos proyectos de CIC bioGUNE. Uno de ellos acercará a la práctica clínica una nueva terapia basada en anticuerpos para frenar la metástasis del c...

A project for the early diagnosis of colorectal cancer receives support from the 'la Caixa' Foundation

by IRB Barcelona - Instituto de Investigación Biomédica

6 months ago
Colorectal cancer, intestinal microbiota, CaixaImpulse Innovation

“la Caixa” Foundation finances an IRB Barcelona project addressing the analysis of intestinal microbiota combined with Artificial Intelligence (AI) for the early diagnosis of colorectal cancer.